BACKGROUND AND AIMS: The degree of motivation before starting the treatment represents a pre-treatment predictor of successful weight management. The aim of this study is to develop and validate a new self-reported questionnaire of motivation and readiness to change before starting a lifestyle modification program (the TREatment MOtivation and REadiness test) (TRE-MORE) for overweight patients. METHODS AND RESULTS: TRE-MORE was evaluated in a consecutive series of 129 obese patients attending our Outpatient Clinic. Validation of the questionnaire was performed through test-retest reliability, internal consistency, psychopathological correlates, and concurrent validity. Subjects have been evaluated by means of a clinical interview, and different self-reported questionnaires, assessing the eating specific and general psychopathology, and quality of life. TRE-MORE total and subscales scores showed good test-retest reliability and internal consistency. We identified 10 items grouped in 3 areas (obstacles and desire to overcome, taking care of themselves, and sharing the problems, current lifestyle). TREMORE scores were significantly correlated with eating specific psychopathology and quality of life measures. Univariate and Receiver Operating Characteristic curve analysis showed that TRE-MORE total and subscales scores represent a good model for predicting a weight loss >5% of the initial weight after 6 months of treatment. CONCLUSION: TRE-MORE represents a validated and easy-to-use questionnaire assessing at the meantime the treatment motivation and readiness with good predictive capacity for weight loss.
BACKGROUND AND AIMS: The degree of motivation before starting the treatment represents a pre-treatment predictor of successful weight management. The aim of this study is to develop and validate a new self-reported questionnaire of motivation and readiness to change before starting a lifestyle modification program (the TREatment MOtivation and REadiness test) (TRE-MORE) for overweight patients. METHODS AND RESULTS: TRE-MORE was evaluated in a consecutive series of 129 obesepatients attending our Outpatient Clinic. Validation of the questionnaire was performed through test-retest reliability, internal consistency, psychopathological correlates, and concurrent validity. Subjects have been evaluated by means of a clinical interview, and different self-reported questionnaires, assessing the eating specific and general psychopathology, and quality of life. TRE-MORE total and subscales scores showed good test-retest reliability and internal consistency. We identified 10 items grouped in 3 areas (obstacles and desire to overcome, taking care of themselves, and sharing the problems, current lifestyle). TREMORE scores were significantly correlated with eating specific psychopathology and quality of life measures. Univariate and Receiver Operating Characteristic curve analysis showed that TRE-MORE total and subscales scores represent a good model for predicting a weight loss >5% of the initial weight after 6 months of treatment. CONCLUSION: TRE-MORE represents a validated and easy-to-use questionnaire assessing at the meantime the treatment motivation and readiness with good predictive capacity for weight loss.
Authors: E Mannucci; V Ricca; E Barciulli; M Di Bernardo; R Travaglini; P L Cabras; C M Rotella Journal: Addict Behav Date: 1999 May-Jun Impact factor: 3.913
Authors: John B Dixon; Cheryl P Laurie; Margaret L Anderson; Melissa J Hayden; Maureen E Dixon; Paul E O'Brien Journal: Obesity (Silver Spring) Date: 2009-01-15 Impact factor: 5.002
Authors: Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal Journal: JAMA Date: 2004-06-16 Impact factor: 56.272
Authors: P J Teixeira; S B Going; L B Houtkooper; E C Cussler; L L Metcalfe; R M Blew; L B Sardinha; T G Lohman Journal: Int J Obes Relat Metab Disord Date: 2004-09
Authors: Olivia Johnson; Lynn B Gerald; Jean Harvey; Gem Roy; Heather Hazucha; Chelsey Large; Alyce Burke; Meredith McCormack; Robert A Wise; Janet T Holbrook; Anne E Dixon Journal: J Allergy Clin Immunol Pract Date: 2022-03-15
Authors: Francesco Rotella; Lisa Lazzeretti; Valeria Barbaro; Giovanni Castellini; Michela Bigiarini; Barbara Cresci; Valdo Ricca; Carlo Maria Rotella; Edoardo Mannucci Journal: J Endocrinol Invest Date: 2014-07-20 Impact factor: 4.256
Authors: Barbara Cresci; Giovanni Castellini; Laura Pala; Michela Bigiarini; Ester Romoli; Roberta Poggiali; Cosetta Guarnieri; Barbara Biffi; Teresa La Ferlita; Valdo Ricca; Edoardo Mannucci; Carlo Maria Rotella Journal: Obes Facts Date: 2013-06-18 Impact factor: 3.942
Authors: Barbara Cresci; Laura Pala; Roberta Poggiali; Cosetta Guarnieri; Edoardo Mannucci; Michela Bigiarini; Carlo Maria Rotella Journal: Eat Weight Disord Date: 2014-05-11 Impact factor: 4.652